Sinovac Biotech Ltd
NASDAQ:SVA
Sinovac Biotech Ltd
EPS (Diluted)
Sinovac Biotech Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sinovac Biotech Ltd
NASDAQ:SVA
|
EPS (Diluted)
$0
|
CAGR 3-Years
38%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
EPS (Diluted)
-¥4
|
CAGR 3-Years
17%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
EPS (Diluted)
¥0
|
CAGR 3-Years
4%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-5%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
EPS (Diluted)
¥3
|
CAGR 3-Years
10%
|
CAGR 5-Years
24%
|
CAGR 10-Years
43%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
EPS (Diluted)
¥5
|
CAGR 3-Years
46%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
See Also
What is Sinovac Biotech Ltd's EPS (Diluted)?
EPS (Diluted)
0.9
USD
Based on the financial report for Dec 31, 2022, Sinovac Biotech Ltd's EPS (Diluted) amounts to 0.9 USD.
What is Sinovac Biotech Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
16%
Over the last year, the EPS (Diluted) growth was -99%. The average annual EPS (Diluted) growth rates for Sinovac Biotech Ltd have been 38% over the past three years , 16% over the past five years .